NeuroRx, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.neurorxpharma.com
Clinical Trials
8
Active:2
Completed:3
Trial Phases
2 Phases
Phase 2:5
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (71.4%)Phase 3
2 (28.6%)NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis
Phase 2
Not yet recruiting
- Conditions
- PyelonephritisUrinary Tract Infections
- Interventions
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT06128213
NRX-101 Expanded Access
- Conditions
- Bipolar Affective DisorderBipolar Depression
- First Posted Date
- 2023-03-22
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- NeuroRx, Inc.
- Registration Number
- NCT05779267
Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- NeuroRx, Inc.
- Registration Number
- NCT04990466
NRX101 Glx Biomarker Validation Study
Phase 2
Completed
- Conditions
- Bipolar DepressionSuicidal Ideation
- Interventions
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03402152
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
Phase 3
Active, not recruiting
- Conditions
- Bipolar DepressionSuicidal Ideation
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-01-11
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT03396601
- Locations
- 🇺🇸
Research Centers of America, Hollywood, Florida, United States
🇺🇸JP Smith Hospital, Fort Worth, Texas, United States
- Prev
- 1
- 2
- Next
News
No news found